Publications by authors named "Mark A Matson"

Claim this Profile
F
First-in-Human Phase I Clinical Trial of the Adenosine A1R/A3R Agonist AST-004 in Healthy Subjects.
Lisa M Manna, Juan Hernandez, Dawn E Hunt, Géza Lakner, Mark A Matson

Stroke· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy results of simulated post-exposure prophylaxis with human immune globulin (HRIG; KEDRAB) co-administered with active vaccine in healthy subjects: a comparative phase 2/3 trial.
Mark A Matson, Eran Schenker, Michal Stein, Vladislava Zamfirova, Huy-Binh Nguyen

Hum Vaccin Immunother· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Pharmacodynamic Responses of the Novel Cancer Immunotherapeutic Imprime PGG in Healthy Volunteers.
Nandita Bose, Nadine R Ottoson, Xiaohong Qiu, Ben Harrison, Jamie R Lowe, Mark A Matson

J Immunol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune characteristics correlating with HSV-1 immune control and effect of squaric acid dibutyl ester on immune characteristics of subjects with frequent herpes labialis episodes.
Hugh McTavish, Katherine W Zerebiec, Jay C Zeller, Laurie L Shekels, Mark A Matson

Immun Inflamm Dis· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A short 2 week dose titration regimen reduces the severity of flu-like symptoms with initial interferon gamma-1b treatment.
John G Devane, Mary L Martin, Mark A Matson

Curr Med Res Opin· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of MK-5046, a bombesin receptor subtype-3 (BRS-3) agonist, in healthy patients.
Marc L Reitman, Victor Dishy, Allison Moreau, William S Denney, Chengcheng Liu, Mark A Matson

J Clin Pharmacol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose titration of intramuscular interferon beta-1a reduces the severity and incidence of flu-like symptoms during treatment initiation.
Mark A Matson, Thomas R Zimmerman, Dianne Tuccillo, Yongqiang Tang, Aaron Deykin

Curr Med Res Opin· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis